Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in PROTAGONIST THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 104,528 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $9.1M as of 2025-Q4. The position was decreased (-5.2% shares). PTGX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$9.1M
Current Shares
104,528
Total Value Change
-$3.7M
Total Shares Change
-265,427
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A., BlackRock, Inc.
Decreased |
| 104,528 |
-5.2% |
| $9.1M |
| 0.0% |
| $87.26 |
0 |
| 2025-Q3 | Decreased | 110,229 | -54.7% | $7.3M | 0.0% | $65.14 | 0 |
| 2025-Q2 | Increased | 243,373 | +16.6% | $13.5M | 0.0% | $55.69 | 32 |
| 2025-Q1 | Decreased | 208,756 | -27.5% | $10.1M | 0.0% | $48.88 | 0 |
| 2024-Q4 | Decreased | 287,911 | -21.8% | $11.1M | 0.0% | $38.51 | 0 |
| 2024-Q3 | Decreased | 368,132 | -0.5% | $16.6M | 0.0% | $44.56 | 0 |
| 2024-Q2 | Increased | 369,955 | +10.3% | $12.8M | 0.0% | $34.65 | 31 |